期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌内分泌治疗耐药的研究进展 被引量：9

Research Progress on Drug Resistance of Endocrine Therapy for Breast Cancer
原文传递
导出
摘要 乳腺癌内分泌治疗作为乳腺癌综合治疗的方法之一,具有不可替代的重要性。然而,内分泌治疗的疗效因其耐药性受到限制。文章旨在对乳腺癌内分泌治疗耐药的机制及逆转耐药的治疗进展进行综述,为临床内分泌治疗提供新的方向。 Endocrine therapy is part of comprehensive treatment in breast cancer with irreplaceable importance. However,the drug resistance of endocrine therapy restricts its efficacy. This paper aims to review the mechanism of endocrine resistance in breast cancer,and to summarize the advanced therapeutic methods of reversing drug resistance and to provide a new direction for endocrine therapy in clinic.
作者 于付 郑荣生
机构地区 蚌埠医学院第一附属医院
出处 《中国肿瘤》 CAS CSCD 2017年第5期388-394,共7页 China Cancer
关键词 乳腺癌 内分泌治疗 耐药 靶向治疗 breast cancer endocrine therapy drug resistance targeted therapy
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献2

二级参考文献19

  • 1Nicholson R I, Hutcheson I R, Knowlden J M,et al. Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combination[J].Clin Cancer Res,2004,10(1 Pt 2):346-354.
  • 2Knowlden J M, Hutcheson I R, Jones H E,et al. Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells[J]. Endocrinology,2003,144 (3):1032-1044.
  • 3Jordan N J, Gee J M, Barrow D,et al. Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells[J].Breast Cancer Res Treat,2004,87(2):167-180.
  • 4Witters L, Engle L, Lipton A. Restoration of estrogen responsiveness by blocking the HER-2/neu pathway[J]. Oncol Rep,2002,9(6) : 1163-1166.
  • 5Fuqua S A, Wiltschke C, Zhang Q X, et al. A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions[J].Cancer Res,2000,60(15) :4026-4029.
  • 6Santen R J, Song R X, Zhang Z,et al. Adaptive hypersensitivity to estrogen: mechanism for sequential responses to hormonal therapy in breast cancer[J].Clin Cancer Res,2004,10(1 Pt 2):337-345.
  • 7Johnston S R, Dowsett M. Aromatase inhibitors for breast cancer: lessons from the laboratory[J]. Nat Rev Cancer, 2003,3(11):821-831.
  • 8Martin L A, Farmer I, Johnston S R, et al. Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation[J].J Biol Chem, 2003, 278 (33) :30458--30468.
  • 9Stoica A, Saceda M, Fakhro A,et al. Role of insulin-like growth factor Ⅰ in regulating estrogen receptor-alpha gene expression[J].J Cell Biochem,2000,76(4) :605-614.
  • 10Oh A S, Lorant L A, Holloway J N, et al. Hyperactivation of MAPK induces loss of ERαlpha expression in breast cancer cells[J]. Mol Endocrinol,2001,15(8) : 1344-1359.

共引文献18

同被引文献44

引证文献9

二级引证文献22

中国肿瘤
2017年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部